Make a difference in patient care.
Make brain hemorrhage monitoring a reality.

Development Pipeline

Investment to Date

Non-dilutive grant money $1,500,000.

Sense Diagnostics has also raised a seed round of $1,200,000.

Queen City Angels

(Cincinnati)

Accelerant Fund

(Dayton, OH)

Strategic Neuro
Physician Investors

National Science
Foundation

Investment Opportunity

Series B: Participating preferred, 6% interest, 1x liquidation preference.

Milestones

Finish pilot study

Pivotal hospital study

510K de novo filing

Begin EU approval work

Add strategic relations/business development executive

(candidate identified)

Why Invest

Important unmet clinical need

Large target market

Promising early product results

Multiple applications

Elligible for opportunity zones benefits

Distinct advantages over competition

Strong clinical/technical team

Experienced leadership team

Issued IP with broad application for brain conditions

Join Us

Our team works diligently to make our innovative brain scanner a reality for patients. We are driven by our mission and are committed to impacting people's lives and enhancing neurological health globally.

Join Us

Our team works diligently to make our innovative brain scanner a reality for patients. We are driven by our mission and are committed to impacting people's lives and enhancing neurological health globally.